
	Twelve Months Ended December 31,
	2025		2024
Segment revenue	$	145,905	$	103,865
Less:
Employee expense	67,735		66,847
Travel and expense	4,318		6,043
Capitalized R&D expense	(5,217)		(6,027)
Stock-based compensation expense1	20,571		24,756
Other non-recurring expenses2	8,119		17,212
Consulting and contract staffing	11,841		12,732
Software subscriptions	6,365		6,814
Depreciation and amortization	24,340		17,375
Restructuring costs	2,662		860
Loss on disposal of property and equipment	3,787		—
Other cost of revenue	32,974		18,320
Other operating expenses	16,873		21,240
Other segment items3	(15,325)		(28,290)


Segment net (loss) income	$	(33,138)	$	(54,017)

1 Excludes incremental expense related to modified awards included in the Restructuring costs line. See Note 22, Restructuring Charges for additional information.

2 For the year ended December 31, 2025, includes consulting and legal fees and additional audit fees incurred in connection with a previously disclosed investigation and restatement of prior period financial statements, net of estimated insurance recoveries, as well as estimated net losses related to ongoing legal matters. For the year ended December 31, 2024, includes each of the costs described above, as well as costs associated with adverse non-cancellable inventory purchase commitments, inventory reserve associated with the transition of our manufacturing operations to the next generation of Evolv Express systems and the determination that certain components within our legacy systems will not be used in the next generation systems, and severance expense.